Skip to content

Home-based Treatment of Patients With Chronic Obstructive Pulmonary Disease (COPD)

Randomised Clinical Study on the Effect of Home-based Treatment of Patients With COPD. Improved Cooperation Between Hospital and Primary Healthcare System.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00702078
Acronym
COPD-HOME
Enrollment
172
Registered
2008-06-20
Start date
2008-04-30
Completion date
2015-12-31
Last updated
2017-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, home-based treatment, early intervention

Brief summary

We want to improve the treatment of patients suffering from COPD (3-4) by early medical intervention in the patients home. A close cooperation between the hospital and the primary healthcare system will hopefully reduce hospitalisation, drug consumption and improve quality of life. Following up from the hospital and the primary healthcare in cooperation may lead to earlier detection and treatment of exacerbations in COPD. The main outcome variable will be number of hospitalizations assessed simply by counting. The second objective will be Quality of life and activation assessed by different questionnaires included in St.George´s Respiratory Questionnaire.

Interventions

BEHAVIORALcloser collaboration between hospital and primary healthcare system

Follow-up from the hospital and the primary healthcare in cooperation

BEHAVIORALusual care

follow-up according to todays best practice

Sponsors

Community Health Network
CollaboratorOTHER
St. Olavs Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 95 Years
Healthy volunteers
No

Inclusion criteria

* clinical diagnosis of COPD (III-IV) * receive help from homecare nurse * not suffering from any other serious disease, with expected lifespan less than 6 months

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frame
Number of hospitalizations2011

Secondary

MeasureTime frame
quality of life2011
lung function2011
use of medication2011
cost-effectiveness2011

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026